Research ArticleArticle
Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer
Kathryn E. Cronise, Belen G. Hernandez, Daniel L. Gustafson and Dawn L. Duval
Molecular Pharmacology July 2019, 96 (1) 36-46; DOI: https://doi.org/10.1124/mol.119.115808
Kathryn E. Cronise
Flint Animal Cancer Center, Department of Clinical Sciences (K.E.C., B.G.H., D.L.G., D.L.D.), and Cell and Molecular Biology Graduate Program (K.E.C., D.L.G., D.L.D.), Colorado State University, Fort Collins, Colorado; and University of Colorado Cancer Center, Aurora, Colorado (D.L.G., D.L.D.)
Belen G. Hernandez
Flint Animal Cancer Center, Department of Clinical Sciences (K.E.C., B.G.H., D.L.G., D.L.D.), and Cell and Molecular Biology Graduate Program (K.E.C., D.L.G., D.L.D.), Colorado State University, Fort Collins, Colorado; and University of Colorado Cancer Center, Aurora, Colorado (D.L.G., D.L.D.)
Daniel L. Gustafson
Flint Animal Cancer Center, Department of Clinical Sciences (K.E.C., B.G.H., D.L.G., D.L.D.), and Cell and Molecular Biology Graduate Program (K.E.C., D.L.G., D.L.D.), Colorado State University, Fort Collins, Colorado; and University of Colorado Cancer Center, Aurora, Colorado (D.L.G., D.L.D.)
Dawn L. Duval
Flint Animal Cancer Center, Department of Clinical Sciences (K.E.C., B.G.H., D.L.G., D.L.D.), and Cell and Molecular Biology Graduate Program (K.E.C., D.L.G., D.L.D.), Colorado State University, Fort Collins, Colorado; and University of Colorado Cancer Center, Aurora, Colorado (D.L.G., D.L.D.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
MAPK and ErbB Inhibition Synergize in Canine Bladder Cancer
Kathryn E. Cronise, Belen G. Hernandez, Daniel L. Gustafson and Dawn L. Duval
Molecular Pharmacology July 1, 2019, 96 (1) 36-46; DOI: https://doi.org/10.1124/mol.119.115808
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement